| Dr Anna Lucy Sobol, MD | |
|
336 Deerfield Rd, Boone, NC 28607-5008 | |
| (828) 262-4100 | |
| (828) 262-4103 |
| Full Name | Dr Anna Lucy Sobol |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 21 Years |
| Location | 336 Deerfield Rd, Boone, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386627677 | NPI | - | NPPES |
| 5912312 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2009-01642 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watauga Medical Center | Boone, NC | Hospital |
| Charles A Cannon Jr Memorial Hospital | Linville, NC | Hospital |
| Ashe Memorial Hospital | Jefferson, NC | Hospital |
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watauga Medical Center Inc | 2668377474 | 72 |
News Archive
Pfizer Inc. announced today that the Food and Drug Administration (FDA) issued a Complete Response letter regarding the company's New Drug Application (NDA) for Lyrica® (pregabalin) capsules CV as a monotherapy treatment for generalized anxiety disorder (GAD). The FDA determined that the data contained in the NDA were insufficient to support approval.
Scientists have found that key metabolites in blood - chemical 'fingerprints' left behind as a result of early molecular changes before birth or in infancy - could provide clues to a person's long-term overall health and rate of ageing in later life.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team.
The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the second quarter ended June 30, 2010.
› Verified 1 days ago
| Entity Name | Watauga Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528134194 PECOS PAC ID: 2668377474 Enrollment ID: O20040210000805 |
News Archive
Pfizer Inc. announced today that the Food and Drug Administration (FDA) issued a Complete Response letter regarding the company's New Drug Application (NDA) for Lyrica® (pregabalin) capsules CV as a monotherapy treatment for generalized anxiety disorder (GAD). The FDA determined that the data contained in the NDA were insufficient to support approval.
Scientists have found that key metabolites in blood - chemical 'fingerprints' left behind as a result of early molecular changes before birth or in infancy - could provide clues to a person's long-term overall health and rate of ageing in later life.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team.
The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the second quarter ended June 30, 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna Lucy Sobol, MD 336 Deerfield Rd, Boone, NC 28607-5008 Ph: (828) 262-4100 | Dr Anna Lucy Sobol, MD 336 Deerfield Rd, Boone, NC 28607-5008 Ph: (828) 262-4100 |
News Archive
Pfizer Inc. announced today that the Food and Drug Administration (FDA) issued a Complete Response letter regarding the company's New Drug Application (NDA) for Lyrica® (pregabalin) capsules CV as a monotherapy treatment for generalized anxiety disorder (GAD). The FDA determined that the data contained in the NDA were insufficient to support approval.
Scientists have found that key metabolites in blood - chemical 'fingerprints' left behind as a result of early molecular changes before birth or in infancy - could provide clues to a person's long-term overall health and rate of ageing in later life.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team.
The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the second quarter ended June 30, 2010.
› Verified 1 days ago
Dr. Laura B. Denouden- Dunn, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 614 Howard St, Boone, NC 28608 Phone: 828-262-3100 | |
Richard Rey Stark, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 148 Highway 105 Ext, Suite 104, Boone, NC 28607 Phone: 828-386-2746 Fax: 828-386-2750 | |
Dr. Marion Timothy Wells, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 336 Deerfield Rd, Boone, NC 28607 Phone: 828-264-9664 Fax: 828-262-4103 | |
Peter Thomas Ashline, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 175 Mary St, Boone, NC 28607 Phone: 828-264-9664 Fax: 828-264-8144 | |
Khurram Bilal Tariq, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 338 Deerfield Road, Boone, NC 28607 Phone: 828-262-4332 Fax: 828-265-5514 | |
Dr. Kevin W. Wolfe, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 136 Furman Rd, Suite 6, Boone, NC 28607 Phone: 828-268-1185 Fax: 828-265-8522 | |
Dr. Peter Joseph Haibach, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 136 Furman Rd, Suite 7, Boone, NC 28607 Phone: 828-262-0060 Fax: 828-262-0062 |